(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Living Abroad: Social Inundation and Self-improvement - 2Artemis II astronauts arrive at Florida launch site for first moon trip in 53 years
- 3DEA seizes 1.7 million counterfeit fentanyl pills in Colorado storage unit
- 4See as Your #1: These Low-Sugar Food sources You Ought to Attempt
- 5Thousands of New York City nurses set to strike Monday if deal isn't reached with hospitals
- Australia Cracks Down on Gambling Ads as Prediction Markets Like Polymarket Remain Blocked
- Vote in favor of your Number one kind of juice
- Which camera do you believe is great for first-time clients? !
- Grasping the Elements of Medical caretaker Pay rates: Factors That Shape Your Pay
- The cheap health insurance promoted by Trump officials has this catch
- The many ways that baking is winter therapy. With a delicious ending
- Compassion and Association: Building Significant Connections
- Sun storms are powered by a magnetic engine 16 Earths deep, study finds
- Step into Nature: A Survey of \Handling Trails with Solace\ Climbing Shoes
